Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging
- Authors
- DuPont, Jennifer J.; McCurley, Amy; Davel, Ana P.; McCarthy, Joseph; Bender, Shawn B.; Hong, Kwangseok; Yang, Yan; Yoo, Jeung-Ki; Aronovitz, Mark; Baur, Wendy E.; Christou, Demetra D.; Hill, Michael A.; Jaffe, Iris Z.
- Issue Date
- Sep-2016
- Publisher
- AMER SOC CLINICAL INVESTIGATION INC
- Citation
- JCI INSIGHT, v.1, no.14
- Journal Title
- JCI INSIGHT
- Volume
- 1
- Number
- 14
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/45664
- DOI
- 10.1172/jci.insight.88942
- ISSN
- 2379-3708
2379-3708
- Abstract
- Hypertension is nearly universal yet poorly controlled in the elderly despite proven benefits of intensive treatment. Mice lacking mineralocorticoid receptors in smooth muscle cells (SMC-MR-KO) are protected from rising blood pressure (BP) with aging, despite normal renal function. Vasoconstriction is attenuated in aged SMC-MR-KO mice, thus they were used to explore vascular mechanisms that may contribute to hypertension with aging. MicroRNA (miR) profiling identified miR-155 as the most down-regulated miR with vascular aging in MR-intact but not SMC-MR-KO mice. The aging-associated decrease in miR-155 in mesenteric resistance vessels was associated with increased mRNA abundance of MR and of predicted miR-155 targets Cav1.2 (L-type calcium channel (LTCC) subunit) and angiotensin type-1 receptor (AgtR1). SMC-MR-KO mice lacked these aging-associated vascular gene expression changes. In HEK293 cells, MR repressed miR-155 promoter activity. In cultured SMCs, miR-155 decreased Cav1.2 and AgtR1 mRNA. Compared to MR-intact littermates, aged SMC-MR-KO mice had decreased systolic BP, myogenic tone, SMC LTCC current, mesenteric vessel calcium influx, LTCC-induced vasoconstriction and angiotensin II-induced vasoconstriction and oxidative stress. Restoration of miR-155 specifically in SMCs of aged MR-intact mice decreased Cav1.2 and AgtR1 mRNA and attenuated LTCC-mediated and angiotensin II-induced vasoconstriction and oxidative stress. Finally, in a trial of MR blockade in elderly humans, changes in serum miR-155 predicted the BP treatment response. Thus, SMC-MR regulation of miR-155, Cav1.2 and AgtR1 impacts vasoconstriction with aging. This novel mechanism identifies potential new treatment strategies and biomarkers to improve and individualize antihypertensive therapy in the elderly.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Education > Department of Physical Education > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.